COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies

COVID‐19 is associated with high mortality in patients with haematological malignancies (HM) and rate of seroconversion is unknown. The ITA‐HEMA‐COV project (NCT04352556) investigated patterns of seroconversion for SARS‐CoV‐2 IgG in patients with HMs. A total of 237 patients, SARS‐CoV‐2 PCR‐positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Passamonti, Francesco, Romano, Alessandra, Salvini, Marco, Merli, Francesco, Porta, Matteo G. Della, Bruna, Riccardo, Coviello, Elisa, Romano, Ilaria, Cairoli, Roberto, Lemoli, Roberto, Farina, Francesca, Venditti, Adriano, Busca, Alessandro, Ladetto, Marco, Massaia, Massimo, Pinto, Antonio, Arcaini, Luca, Tafuri, Agostino, Marchesi, Francesco, Fracchiolla, Nicola, Bocchia, Monica, Armiento, Daniele, Candoni, Anna, Krampera, Mauro, Luppi, Mario, Cardinali, Valeria, Galimberti, Sara, Cattaneo, Chiara, La Barbera, Elettra Ortu, Mina, Roberto, Lanza, Francesco, Visani, Giuseppe, Musto, Pellegrino, Petrucci, Luigi, Zaja, Francesco, Grossi, Paolo A., Bertù, Lorenza, Pagano, Livio, Corradini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444788/
https://www.ncbi.nlm.nih.gov/pubmed/34272724
http://dx.doi.org/10.1111/bjh.17704

Ejemplares similares

Ejemplares similares